U.S. STOCKS ON THE MOVE-Heartbeam, Aura Biosciences, U.S. banks
Heartbeam Inc gains on U.S. patent for heart device
Brief: Heartbeam Inc - Heartbeam Granted Patent For Signal Transformation From Vector Electrocardiogram (VECG) To 12-Lead Electrocardiogram (ECG)
U.S. STOCKS ON THE MOVE-HeartBeam, Duckhorn Portfolio, Danaher
HeartBeam surges on U.S. patent for heart device
U.S. STOCKS ON THE MOVE-Adobe, Netflix, FTC Solar
Brief: HeartBeam Granted Patent For ECG Patch Monitor For Detection Of Heart Attacks
Brief: Heartbeam announces FDA submission of Heartbeam Aimi™ product
Brief: Heartbeam Reports Second Quarter 2022 Financial Results
Brief: Heartbeam Inc Expects To File 510K No Later Than August 15, 2022
Brief: Heartbeam Reports First Quarter 2022 Financial Results
Brief: Heartbeam Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: Heartbeam Inc - On January 31, Entered Into A Partnership Agreement With Livmor
Brief: HeartBeam Reports Q3 Net Loss Per Share Of $0.32
Brief: Heartbeam Announces Closing Of Initial Public Offering
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
Brief: Heartbeam Says IPO Of 2.75 Mln Units Priced At $6.00 Unit
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:59 AM